More than 10 million people worldwide live with Crohn’s Disease or Ulcerative colitis, which can be classified as Inflammatory Bowel Diseases. May 19th is nationally recognized as a day of awareness for Inflammatory Bowel Disease. IBD, as the name implies, is characterized by inflammation in the GI tract, but the location, symptoms, and severity all range from one person to the next. Understanding triggers and developing a deep body awareness are common for those with IBD. This year, the Crohn’s & Colitis foundation reminds everyone that IBD has no borders and can affect anyone, independent of location. This year’s awareness hashtag is #IBDBeyondBorders.
In Pennsylvania, IBD is one of the approved medical conditions for which treatment by medical marijuana is appropriate. Certain cannabinoids have been identified to have powerful anti-inflammation effects that can help with the symptoms of IBD. CBD can modulate the effect of the enteric glial cells to reduce inflammation in the GI tract. In fact, treatment with CBD has been seen to be so effective that it can prevent inflammation entirely when used preventatively.
The synergistic effect of cannabinoids, or entourage effect, is thought to aid in the treatment of IBD by medical marijuana. For this reason, treatment using both THC and CBD is thought to be more powerful than using isolated cannabinoids.